Safety Study of Nebivolol for COPD Patients

Withdrawn before enrolling · Phase 2/Phase 3 · Has a placebo group

Conditions studied: High Blood Pressure

In brief

The purpose of this study is to demonstrate the safety and effectiveness of the study drug Nebivolol, in people who suffer with high blood pressure with Chronic Obstructive Pulmonary Disease (COPD).

Key facts

Study ID

NCT01939990

Run by

University of Chicago

People needed

0

Starts

2012-01-01

Expected to finish

2013-03-01

Last updated by the study team

2016-01-12

Who can join

Age: 40 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Clinical diagnosis of high blood pressure and chronic obstructive pulmonary disease (COPD)

You may not qualify if…

• Asthma; Heart failur;
• End stage kidney disease;
• acute myocardial infarction,unstable angina, stroke or TIA within the past year;
• Females who are pregnant, lactating or women of childbearing potential who are not using approved method of contraception.

Where it is running

• University of Chicago Medical Center — Chicago, Illinois, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.